SEARCH

SEARCH BY CITATION

References

  • Aceitero JMR (2000) Surveys on the rates of healthy carriers of Neisseria meningitidis and characterization of circulating strains. Revista Espanola de Salud Publica 74, 413417.
  • Adams WG, Deaver KA, Cochi SL et al. (1993) Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. Journal of the American Medical Association 269, 221226.
  • Adegbola RA, Mulholland EK, Secka O, Jaffar S & Greenwood BM (1998) Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. Journal of Infectious Diseases 177, 17581761.
  • Adegbola RA, Secka O, Lahai G et al. (2005) Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 366, 144150.
  • Artenstein MS, Gold R, Zimmerly JG et al. (1970) Prevention of meningococcal disease by group C polysaccharide vaccine. New England Journal of Medicine 282, 417420.
  • Barbour ML, Mayon-White RT, Coles C, Crook DWM & Moxon ER (1995) The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. Journal of Infectious Diseases 171, 9398.
  • Bjune G (1992) ‘Herd immunity’ and the meningococcal vaccine trial in Norway. Lancet 340, 315.
  • Blakebrough IS, Greenwood BM, Whittle H, Bradley AK & Gilles HM (1983) Failure of meningococcal vaccination to stop the transmission of meningococci in Nigerian schoolboys. Annals of Tropical Medicine and Parasitology 77, 175178.
  • Boisier P, Nicolas P, Djibo S et al. (2007) Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in Niger in 2006. Clinical Infectious Diseases 44, 657663.
  • Boslego J, Garcia J, Cruz C et al. (1995) Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease. Vaccine 13, 821829.
  • Bosmans E, Vimont-Vicary P, Andre FE et al. (1980) Protective efficacy of a bivalent (A  +  C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. Annales de la Société Bélge Médecine Tropicale 60, 297306.
  • Cardenosa N, Dominguez A, Orcau A et al. (2001) Carriers of Neisseria meningitidis in household contacts of meningococcal disease cases in Catalonia (Spain). European Journal of Epidemiology 17, 877884.
  • Caugant DA, Fogg C, Bajunirwe C et al. (2006) Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 11591163.
  • Chippaux JP, Debois H & Saliou P (2002) A critical review of control strategies against meningococcal meningitis epidemics in sub-Saharan African countries. Infection 30, 216224.
  • Cogwill KD, Ndiritu M, Nyiro J et al. (2006) Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. Journal of the American Medical Association 296, 671678.
  • Cutts FT, Zaman SM, Enwere G et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365, 11391146.
  • Dagan R, Muallem M, Melamed R, Leroy O & Yagupsky P (1997) Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatric Infectious Diseases Journal 16, 10601064.
  • Decosas J & Koama J-B (2002) Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infectious Diseases 2, 763765.
  • Devine LE, Pierce WE, Floyd TM et al. (1970) Evaluation of group C meningococcal polysaccharide vaccine in marine recruits, San Diego, California. American Journal of Epidemiology 92, 2532.
  • Dimartino M, Cali G, Astorre P et al. (1990) Meningococcal carriage and vaccination in army recruits in Italy. Bollettino dell Istituto Sieroterapico Milanese 69, 357359.
  • Djibo S, Nicolas P, Alonso JM et al. (2003) Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000. Tropical Medicine and International Health 8, 11181123.
  • Djibo S, Nicolas P, Campagne G & Chippaux JP (2004) Pharyngeal carriage of Neisseria meningitidis in a school of Niamey, Niger. Medecine Tropicale 64, 363366.
  • Dominguez A, Cardenosa N, Izquierdo C et al. (2001) Prevalence of Neisseria meningitidis carriers in the school population of Catalonia, Spain. Epidemiology and Infection 127, 425433.
  • Eslami-Nejad Z, Esmaili M, Saiis-Adeli N et al. (2005) Neisseria meningitidis carrier rate among military recruits in Kerman, South-east of Iran. Archives of Iranian Medicine 8, 304310.
  • Fernandez S, Arreaza L, Santiago I et al. (2003) Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C. Journal of Medical Microbiology 52, 7577.
  • Finkelstein JA, Huang SS, Daniel J et al. (2003) Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 112, 862869.
  • Forgor AA, Leimkugel J, Hodgson A et al. (2005) Emergence of W135 meningococcal meningitis in Ghana. Tropical Medicine and International Health 10, 12291234.
  • Gagneux SP, Hodgson A, Smith TA et al. (2002) Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. Journal of Infectious Diseases 185, 618626.
  • Ghaffar F, Barton T, Lozano J et al. (2004) Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clinical Infectious Diseases 39, 930938.
  • Gotschlich EC, Goldschneider I & Artenstein MS (1969) Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. Journal of Experimental Medicine 129, 13851395.
  • Greenwood BM (1999) Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 341353.
  • Greenwood BM (2006) 100 years of epidemic meningitis in West Africa – has anything changed? Tropical Medicine and International Health 11, 773780.
  • Greenwood BM, Hasasan-King M & Whittle HC (1978) Prevention of secondary cases of meningococcal disease in household contacts by vaccination. British Medical Journal 1, 13171319.
  • Hammitt LL, Bruden DL, Butler JC et al. (2006) Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. Journal of Infectious Diseases 193, 14871494.
  • Hassan-King MK, Wall RA & Greenwood BM (1988) Meningococcal carriage, meningococcal disease and vaccination. Journal of Infection 16, 5559.
  • Hodgson A, Boutriau D & Begg N (2006) Feasibility of integrating a DTPwHBV/Hib-MenAC combination vaccine within the routine EPI in developing countries. Initiative for Vaccine Research (IVR), Global Vaccine Research Forum, Bangkok, Thailand.
  • Klugman KP (2001) Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infectious Diseases 1, 8591.
  • Klugman KP, Mahdi SA, Huebner RE et al. (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. New England Journal of Medicine 349, 13411348.
  • Laforce FM, Konde K, Viviani S & Preziosi MP (2007) The Meningitis Vaccine Project. Vaccine (in press).
  • Lucero MG for the ARIVAC Consortium (2006) Effectiveness of an 11-valent pneumococcal conjugate vaccine for preventing radiologically confirmed pneumonia in children under 2 years of age: a randomized, double-blind, placebo-controlled trial in the Philippines (ARIVAC). 12th International Conference on Infectious Diseases, Lisbon, June 2006 abstract.
  • Maiden MC, Stuart JM & Group UKMC (2002) Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359, 18291831.
  • Makela P, Kayhty H, Weckstrom P, Sivonen A & Renkonen OV (1975) Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet 2, 883836.
  • Masterton RG, Youngs ER, Wardle JC, Croft KF & Jones DM (1988) Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine. Journal of Infection 17, 177182.
  • McVernon J, Howard AJ, Slack MPE & Ramsay ME (2004) Long-term impact of vaccination on Haemophilus influenzae type b (Hib) carriage in the United Kingdom. Epidemiology and Infection 132, 765767.
  • Miller E, Salisbury D & Ramsay M (2001) Planning, registration and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story. Vaccine 20(Suppl), S5867.
  • Mueller JE, Yaro S, Traore Y et al. (2006) Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso 2003. Journal of Infectious Diseases 193, 812820.
  • Murphy YV, Pastor PN, Medley FB, Osterholm MT & Granoff DM (1993) Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b vaccines. Journal of Pediatrics 122, 517523.
  • Neal KR, Irwin DJ, Davies S, Kaczmarski EB & Wale MC (1998) Sustained reduction in the carriage of Neisseria meningitidis as a result of a community meningococcal disease control programme. Epidemiology and Infection 121, 487493.
  • O’Brien KL & Dagan R (2003) The potential indirect effect of conjugate vaccines. Vaccine 21, 18151825.
  • Obaro SK, Adegbola RA, Banya WA & Greenwood BM (1996) Carriage of pneumococci after pneumococcal vaccination. Lancet 348, 271272.
  • Pavlopoulou ID, Daikos GL, Alexandrou H et al. (2004) Carriage of Neisseria meningitidis by Greek children: risk factors and strain characteristics. Clinical Microbiology and Infection 10, 137142.
  • Peltola H (2000) Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century; a global analysis of the disease burden 25 years after the use of polysaccharide vaccine and a decade after the advent of conjugates. Clinical Microbiology Reviews 13, 302317.
  • Perkins BA, Jonsdottir K, Briem H et al. (1998) Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. Journal of Infectious Diseases 177, 683691.
  • Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB & Miller E (2003) Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. British Medical Journal 326, 365366.
  • Sivonen A (1981) Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates. Journal of Infection 3, 266272.
  • Smith I, Lehmann AK, Lie L et al. (1999) Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. Epidemiology and Infection 123, 373382.
  • Sanborn WR, Bencic Z, Cvjetanovic B et al. (1972) Trial of a serogroup A meningococcus polysachharide vaccine in Nigeria. Progress in Immunobiological Standardization 5, 497505.
  • Stroffolini T, Angelini L, Galanti I et al. (1990) The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state. Microbiologica 13, 225229.
  • Takala AK, Eskola J, Leinonen M et al. (1991) Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. Journal of Infectious Diseases 164, 982986.
  • Traoré Y, Njanpop-Lafourcade BM, Adjogble KLS et al. (2006) The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso 2002-2005. Clinical Infectious Diseases 43, 817822.
  • Trotter CL, Ramsay ME & Kaczmarski EB (2002) Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign. Communicable Disease and Public Health 5, 220225.
  • Trotter C, Ramsay M, Gray S et al. (2006) No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales. The Lancet Infectious Diseases 6, 616617.
  • Wahdan MH, Sallam SA, Hassan MN et al. (1977) A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria. Bulletin of the World Health Organization 55, 645651.
  • Wenzel RP, Mitzel JR, Davies JA et al. (1973) Antigenicity of a polysaccharide vaccine from Neisseria meningitidis administered intranasally. Journal of Infectious Diseases 128, 3140.
  • Whitney CG, Farley MM, Hadler J et al. (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New England Journal of Medicine 348, 17371746.